CureVac N.V. (VIE:CVAC)

Austria flag Austria · Delayed Price · Currency is EUR
4.586
+0.006 (0.13%)
At close: Sep 10, 2025
0.13%
Market Cap1.03B
Revenue (ttm)510.51M
Net Income (ttm)193.64M
Shares Outn/a
EPS (ttm)0.86
PE Ratio5.30
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume92
Open4.572
Previous Close4.580
Day's Range4.572 - 4.590
52-Week Range2.196 - 4.836
Betan/a
RSI46.78
Earnings DateNov 12, 2025

About CureVac

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company’s portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology and instructs human cells to produce or secrete specific proteins in the nucleus, cytoplasm, cellular organelles, and cell membrane. In ad... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 983
Stock Exchange Vienna Stock Exchange
Ticker Symbol CVAC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.